Cys-mc-MMAE is a Drug-Linker Conjugates for ADC, and consists of Monometl auristatin E and a linker. Cys-mc-MMAE can be used for synthesis of ADCs.
References:
[1]. Wang Y, et al. Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety. Cancers (Basel). 2020 Mar 21;12(3):744.
















